Ardsley Advisory Partners’s Sanofi SNY Stock Holding History

Ardsley Advisory Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-7,900	Closed	-$403K	–	176
2020 Q2	$403K	Buy	+7,900	New	+$384K	0.09%	92

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Ardsley Advisory Partners's SNY Position: Q3 2020 in Review

Ardsley Advisory Partners sold out of Sanofi (SNY) in Q3 2020, closing a stake of 7,900 shares — an estimated $403K sold.

Ardsley Advisory Partners first reported a position in SNY in Q2 2020 and held it in 1 quarter. The position peaked at $403K in Q2 2020. 573 funds tracked by Wall St. Rank hold SNY as of Q3 2020.

Ardsley Advisory Partners reported no remaining Sanofi position as of Q3 2020 after selling out during the quarter.
Ardsley Advisory Partners sold 7,900 Sanofi shares in Q3 2020, an estimated $403K.
Ardsley Advisory Partners first reported a position in Sanofi in Q2 2020 and held it in 1 quarter.
Ardsley Advisory Partners's Sanofi position peaked at $403K in Q2 2020.
573 funds tracked by Wall St. Rank held Sanofi as of Q3 2020.

Based on Ardsley Advisory Partners's 13F filing for Q3 2020, filed 13 Nov 2020.